首页> 美国卫生研究院文献>Advances in Medical Education and Practice >Diagnosing COPD: advances in training and practice – a systematic review
【2h】

Diagnosing COPD: advances in training and practice – a systematic review

机译:诊断COPD:培训和实践的进展–系统评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung syndrome, caused by long-term inhalation of noxious gases and particles, which leads to gradual airflow limitation. All health care professionals who care for COPD patients should have full access to high-quality spirometry testing, as postbronchodilator spirometry constitutes the principal method of COPD diagnosis. One out of four smokers 45 years or older presenting respiratory symptoms in primary care, have non-fully reversible airflow limitation compatible with COPD and are mostly without a known diagnosis. Approximately 50.0%–98.3% of patients are undiagnosed worldwide. The majority of undiagnosed COPD patients are isolated at home, are in nursing or senior-assisted living facilities, or are present in oncology and cardiology clinics as patients with lung cancers and coronary artery disease. At this time, the prevalence and mortality of COPD subjects is increasing, rapidly among women who are more susceptible to risk factors. Since effective management strategies are currently available for all phenotypes of COPD, correctly performed and well-interpreted postbronchodilator spirometry is still an essential component of all approaches used. Simple educational training can substantially improve physicians’ knowledge relating to COPD diagnosis. Similarly, a physician inhaler education program can improve attitudes toward inhaler teaching and facilitate its implementation in routine clinical practices. Spirometry combined with inhaled technique education improves the ability of predominantly nonrespiratory physicians to correctly diagnose COPD, to adequately assess its severity, and to increase the percentage of correct COPD treatment used in a real-life setting.
机译:慢性阻塞性肺疾病(COPD)是一种慢性炎症性肺综合症,是由于长期吸入有毒气体和微粒引起的,从而导致气流逐渐受限。所有护理COPD患者的医疗保健专业人员都应有充分的机会接受高质量的肺活量测定测试,因为支气管扩张剂后肺活量测定是COPD诊断的主要方法。 45岁或以上的四分之一吸烟者在初级保健中出现呼吸道症状,其气流受限与COPD不完全可逆,并且大多数患者没有已知的诊断。全世界约有50.0%–98.3%的患者未被诊断。大多数未诊断的COPD患者是在家中隔离的,在护理或高级辅助生活设施中,或者作为肺癌和冠心病的患者存在于肿瘤科和心脏病学诊所。目前,COPD受试者的患病率和死亡率正在迅速增加,而这些妇女更容易受到危险因素的影响。由于目前有效的治疗策略可用于所有COPD的表型,因此正确执行和正确解释的支气管扩张剂后肺活量测定仍是所有使用方法的重要组成部分。简单的教育培训可以极大地提高医师与COPD诊断有关的知识。同样,医师吸入器教育计划可以改善对吸入器教学的态度,并促进其在常规临床实践中的实施。肺活量测定法与吸入式技术教育相结合,可以提高非呼吸内科医师正确诊断COPD,充分评估其严重程度以及增加在现实生活中使用的正确COPD治疗百分比的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号